The device has evolved from one aimed at just functional MR to a broader HF therapy. EMPOWER will provide more insights.

Heart failure; LVEF: Left ventricular ejection fraction; MERIT-HF: Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure; NA: Not available; SENIORS: Study of the Effects of ...

A groundbreaking study in Nature Cardiovascular Research uncovers promising drug targets for heart failure (HF) and its subtypes, offering new hope for precision medicine in cardiology. A recent study ...

The apparent benefits at 2 years observed in the nonrandomized ALT-FLOW study pave the way for a sham-controlled trial.

There is an unmet need for therapies targeting Duchenne muscular dystrophy (DMD)–related heart disease, and phase 2 results suggest ifetroban may improve left ventricular ejection fraction in patients ...

The deaths are also partly the result of medical successes: People are living longer, and more people are surviving heart ...

left ventricular ejection fraction (LVEF), peak oxygen (VO2), and six-minute walk test scores, with heart-failure-related hospitalisations also being assessed as a secondary endpoint. At last year ...

Bayer seeks Japanese marketing approval for finerenone to treat adult patients with chronic heart failure: Berlin Saturday, February 15, 2025, 14:00 Hrs [IST] Bayer announced the ...

Heart failure; LVEF: Left ventricular ejection fraction; MERIT-HF: Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure; NA: Not available; SENIORS: Study of the Effects of ...